These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32966681)

  • 1. Sex-based differences in procedural complications associated with atrial fibrillation catheter ablation: A systematic review and meta-analysis.
    Campbell ML; Larson J; Farid T; Westerman S; Lloyd MS; Shah AD; Leon AR; El-Chami MF; Merchant FM
    J Cardiovasc Electrophysiol; 2020 Dec; 31(12):3176-3186. PubMed ID: 32966681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-related differences in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
    Cheng X; Hu Q; Gao L; Liu J; Qin S; Zhang D
    Europace; 2019 Oct; 21(10):1509-1518. PubMed ID: 31281922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and the risk of ischaemic strokes or intracranial haemorrhages: comparisons of the catheter ablation, medical therapy, and non-atrial fibrillation population.
    Kim M; Yu HT; Kim J; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
    Europace; 2021 Apr; 23(4):529-538. PubMed ID: 33045047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-based differences in safety and efficacy of catheter ablation for atrial fibrillation.
    Yadav R; Milstein J; Blum J; Lazieh S; Yang V; Zhao X; Muquit S; Malwankar J; Marine JE; Berger R; Calkins H; Spragg D
    J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1640-1647. PubMed ID: 37365926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation.
    Sardar P; Nairooz R; Chatterjee S; Wetterslev J; Ghosh J; Aronow WS
    Am J Cardiol; 2014 Apr; 113(7):1173-7. PubMed ID: 24513472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation.
    Liang JJ; Elafros MA; Mullen MT; Muser D; Hayashi T; Enriquez A; Pathak RK; Zado ES; Santangeli P; Arkles JS; Schaller RD; Supple GE; Frankel DS; Garcia FC; Deo R; Lin D; Riley MP; Nazarian S; Dixit S; Marchlinski FE; Callans DJ
    J Cardiovasc Electrophysiol; 2018 Jun; 29(6):823-832. PubMed ID: 29513397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patients.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler DO MJ; Day JD; Mallender C; Osborn JS; Weiss JP; Bunch TJ
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1241-1246. PubMed ID: 28845890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan　- Findings From the AF Frontier Ablation Registry.
    Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y;
    Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
    Romero J; Cerrud-Rodriguez RC; Diaz JC; Rodriguez D; Arshad S; Alviz I; Cerna L; Rios S; Monhanty S; Natale A; Garcia MJ; Di Biase L
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1250-1257. PubMed ID: 31257677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in complications following catheter ablation of atrial fibrillation.
    Ngo L; Ali A; Ganesan A; Woodman R; Adams R; Ranasinghe I
    Eur Heart J Qual Care Clin Outcomes; 2021 Sep; 7(5):458-467. PubMed ID: 33963402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of catheter ablation combined with left atrial appendage occlusion for nonvalvular atrial fibrillation: A systematic review and meta-analysis.
    Jiang Y; Li F; Li D; Cheng Y; Jia Y; Fu H; Pu X; Hu H; Jiang J; Zeng R
    Pacing Clin Electrophysiol; 2020 Jan; 43(1):123-132. PubMed ID: 31721242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: A propensity score-matched analysis.
    Saliba W; Schliamser JE; Lavi I; Barnett-Griness O; Gronich N; Rennert G
    Heart Rhythm; 2017 May; 14(5):635-642. PubMed ID: 28189823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation.
    Kaiser DW; Fan J; Schmitt S; Than CT; Ullal AJ; Piccini JP; Heidenreich PA; Turakhia MP
    JACC Clin Electrophysiol; 2016 Nov; 2(6):703-710. PubMed ID: 29623299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Stroke and Recurrence After AF Ablation in Patients With an Initial Event-Free Period of 12 Months.
    Kochhäuser S; Alipour P; Haig-Carter T; Trought K; Hache P; Khaykin Y; Wulffhart Z; Pantano A; Tsang B; Birnie D; Verma A
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):273-279. PubMed ID: 27933666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.
    Minematsu K; Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Miyamoto S; Murakawa Y; Takeichi M; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S
    Cerebrovasc Dis; 2019; 48(1-2):53-60. PubMed ID: 31578012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Ullal AJ; Kaiser DW; Fan J; Schmitt SK; Than CT; Winkelmayer WC; Heidenreich PA; Piccini JP; Perez MV; Wang PJ; Turakhia MP
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):39-48. PubMed ID: 27782345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: A meta-analysis.
    Saglietto A; De Ponti R; Di Biase L; Matta M; Gaita F; Romero J; De Ferrari GM; Anselmino M
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1040-1047. PubMed ID: 32115777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation.
    Wei Z; Zhang X; Wu H; Xie J; Dai Q; Wang L; Xu B
    Medicine (Baltimore); 2016 Aug; 95(31):e4382. PubMed ID: 27495048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Where There's Smoke, There's Fire? Significance of Atrial Fibrillation in Young Patients.
    Wutzler A; von Ulmenstein S; Attanasio P; Huemer M; Parwani AS; Völk K; Blaschke F; Boldt LH; Haverkamp W
    Clin Cardiol; 2016 Apr; 39(4):229-33. PubMed ID: 26848930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
    Di Biase L; Burkhardt JD; Mohanty P; Sanchez J; Horton R; Gallinghouse GJ; Lakkireddy D; Verma A; Khaykin Y; Hongo R; Hao S; Beheiry S; Pelargonio G; Dello Russo A; Casella M; Santarelli P; Santangeli P; Wang P; Al-Ahmad A; Patel D; Themistoclakis S; Bonso A; Rossillo A; Corrado A; Raviele A; Cummings JE; Schweikert RA; Lewis WR; Natale A
    Circulation; 2010 Jun; 121(23):2550-6. PubMed ID: 20516376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.